Abstract:Author summary Porcine reproductive and respiratory syndrome virus (PRRSV) is one of the most important pathogens in the global swine industry and is difficult to control. CD163 is a receptor that is required for PRRSV infection, and its expression is regulated by various inflammatory mediators. Triggering receptor expressed on myeloid cells 2 (TREM2) is a novel immunoregulatory receptor, which is involved in innate immunity and anti-inflammatory responses. Here we sought to elucidate whether TREM2 regulates CD163 expression to promote PRRSV infection via the inflammatory response. We found increased TREM2 levels upon PRRSV infection in vitro and in vivo in the lungs and lymph nodes of infected pigs. We demonstrated that the cytoplasmic tail of TREM2 interacts with PRRSV Nsp2 to promote infection. Additionally, TREM2 silencing triggers an early proinflammatory response via PI3K/NF-kappa B pathway, thus downregulating the expression of CD163, which leads to virus suppression. Our work provides a novel antiviral mechanism against PRRSV infection and suggests that targeting TREM2 could be a new approach for control of the disease. Triggering receptor expressed on myeloid cells 2 (TREM2) serves as an anti-inflammatory receptor, negatively regulating the innate immune response. TREM2 is mainly expressed on dendritic cells and macrophages, the target cells of porcine reproductive and respiratory syndrome virus (PRRSV). Thus, we investigated the potential role of TREM2 in PRRSV infection in porcine alveolar macrophages (PAMs). We found that there was an increased expression of TREM2 upon PRRSV infection in vitro. TREM2 silencing restrained the replication of PRRSV, whereas TREM2 overexpression facilitated viral replication. The cytoplasmic tail domain of TREM2 interacted with PRRSV Nsp2 to promote infection. TREM2 downregulation led to early activation of PI3K/NF-kappa B signaling, thus reinforcing the expression of proinflammatory cytokines and type I interferons. Due to the enhanced cytokine expression, a disintegrin and metalloproteinase 17 was activated to promote the cleavage of membrane CD163, which resulted in suppression of infection. Furthermore, exogenous soluble TREM2 (sTREM2)-mediated inhibition of PRRSV attachment might be attributed to its competitive binding to viral envelope proteins. In pigs, following PRRSV challenge in vivo, the expression of TREM2 in lungs and lymph nodes as well as the production of sTREM2 were significantly increased. These novel findings indicate that TREM2 plays a role in regulating PRRSV replication via the inflammatory response. Therefore, our work describes a novel antiviral mechanism against PRRSV infection and suggests that targeting TREM2 could be a new approach in the control of the PRRSV infection.

TREM-1 activation modulates dsRNA induced antiviral immunity with specific enhancement of MAPK signaling and the RLRs and TLRs on macrophages

Activation of triggering receptor expressed on myeloid cells-1 protects monocyte from apoptosis through regulation of myeloid cell leukemia-1.

Advance of TREM-1 and Its Role in Sepsis

TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses.

Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages.

Research Advances on TREM-1 Function and Signal Pathway in Pathogenesis

Activation of TREM-1 induces endoplasmic reticulum stress through IRE-1α/XBP-1s pathway in murine macrophages

TREM-2 promotes Th1 responses by interacting with the CD3ζ-ZAP70 complex following Mycobacterium tuberculosis infection

TREM-2 promotes Th1 responses by interacting with the CD3-ZAP70 complex following <i>Mycobacterium tuberculosis</i> infection

Activation of NLRP3 inflammasome up-regulates TREM-1 expression in murine macrophages via HMGB1 and IL-18

sTREM2 Differentially Affects Cytokine Expression in Myeloid-Derived Cell Models via MAPK–JNK Signaling Pathway

Development of Triggering Receptor Expressed on Myeloid Cells-1

Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) Elicited by Lung Cancer Cells to Facilitate Tumor Immune Evasion.

TREM1: Activation, signaling, cancer and therapy

Activation and Regulation of Blood V Delta 2 T Cells Are Amplified by TREM-1(+) During Active Pulmonary Tuberculosis

TREM-1 multimerization is essential for its activation on monocytes and neutrophils

Activation and Regulation of Blood Vδ2 T Cells Are Amplified by TREM-1+ during Active Pulmonary Tuberculosis.

TREM-1 modulates dendritic cell maturation and dendritic cell–mediated T cell activation induced by ox-LDL

Tryptophanyl-tRNA Synthetase 1 Signals Activate TREM-1 via TLR2 and TLR4

TREM2/DAP12 Complex Regulates Inflammatory Responses in Microglia via the JNK Signaling Pathway.

TREM2 suppresses the proinflammatory response to facilitate PRRSV infection via PI3K/NF-B signaling